U.S. psychiatrists are increasingly prescribing the popular weight-loss drug Wegovy to patients who gain weight from medicines used to treat mental disorders, such as schizophrenia or bipolar disorder, according to Reuters interviews with ten prescribers across the country. Many antipsychotic drugs and mood stabilizers can cause patients to gain significant weight and contribute to diabetes and heart disease, the leading cause of death among adults with schizophrenia. Complicated by other factors such as inadequate access to healthy food and lower physical activity, over half of patients with bipolar depression and schizophrenia are overweight or obese.
Related Keywords
New York , United States , Fordham University , Boston , Massachusetts , Denmark , Danish , Michele Gershberg , Mclean Ongur , Michael Weintraub , Natalia Salomao , Elissa Welle , Yorker Alexander Roger , Dost Ongur , Kn Roy Chengappa , Joseph Goldberg , Eli Lilly , Novo Nordisk Wegovy , Reuters , Langone Health , Icahn School Of Medicine At Mount Sinai , University Of Pittsburgh Medical Center , Novo Nordisk , Drug Administration , Icahn School , Mount Sinai , Mass General Brigham Mclean Hospital , Roy Chengappa , Pittsburgh Medical , New Yorker Alexander Roger , Bill Berkrot , Antipsychotic Drugs , Drug Development , Mental Disorders , Psychiatrists , Psychiatric Patients , Bipolar Disorder , Schizophrenia , Obesity Treatment , Suicidal Thoughts , Weight Loss Drug , Weight Gain , Weight Loss , Psychotic Disorders , Food Stabilizers ,
vimarsana.com © 2020. All Rights Reserved.